Matthew Judson is a research associate in the UNC Neuroscience Center at the University of North Carolina at Chapel Hill.

Matthew Judson
Research associate
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.

Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.

Insights for autism from Angelman syndrome
Explore more from The Transmitter
Star-responsive neurons steer moths’ long-distance migration
Cells in the bogong moth brain respond to astral landmarks to orient the insects in the direction they need to go.

Star-responsive neurons steer moths’ long-distance migration
Cells in the bogong moth brain respond to astral landmarks to orient the insects in the direction they need to go.
Exclusive: Issues with dozens of papers prompt inquiry into prolific stroke researcher
Two of John H. Zhang’s papers have been retracted, 19 have corrections, and 27 have expressions of concern.

Exclusive: Issues with dozens of papers prompt inquiry into prolific stroke researcher
Two of John H. Zhang’s papers have been retracted, 19 have corrections, and 27 have expressions of concern.
Nicole Rust on her new book, ‘Elusive Cures’
Rust discusses how understanding the brain as a complex dynamical system will help us accelerate treatments for brain disorders.
Nicole Rust on her new book, ‘Elusive Cures’
Rust discusses how understanding the brain as a complex dynamical system will help us accelerate treatments for brain disorders.